The Positive Effectiveness of Treating Seizures in Newborn Infants

This article provides a comprehensive analysis of the epidemiology, etiology, clinical manifestations, diagnostic approaches, and management strategies for seizures in the neonatal population. Seizures in newborns are a significant neurological emergency and often indicate underlying cerebral dysfunction, making early identification and intervention critical. The article begins with a discussion on the incidence and prevalence of neonatal seizures, highlighting that the condition is more frequent in preterm and low-birth-weight infants. It emphasizes that neonatal seizures are commonly symptomatic, resulting from a variety of causes such as hypoxic-ischemic encephalopathy (HIE), intracranial hemorrhage, infections (e.g., meningitis, TORCH infections), metabolic disturbances (e.g., hypoglycemia, hypocalcemia), and genetic or structural brain abnormalities. A key focus of the article is the clinical presentation of neonatal seizures, which often differ from those in older children and adults. Instead of tonic-clonic movements, neonatal seizures may manifest as subtle signs like lip smacking, eye deviation, or apnea, making diagnosis challenging. The article evaluates the utility of electroencephalography (EEG), including conventional and amplitude-integrated EEG (aEEG), as critical tools for accurate diagnosis, especially in detecting subclinical seizures that may not present with visible symptoms. Therapeutic options are discussed in detail, with phenobarbital remaining the most commonly used first-line antiepileptic drug (AED) in neonatal care, despite ongoing debates about its efficacy and neurotoxicity. The article also reviews emerging alternatives, such as levetiracetam and newer-generation AEDs, and the importance of addressing the underlying etiology alongside symptomatic treatment. The authors explore the short- and long-term prognostic implications of neonatal seizures, noting that seizure burden and delayed treatment are associated with adverse neurodevelopmental outcomes, including cerebral palsy, intellectual disability, and epilepsy. The article underscores the importance of prompt recognition, targeted investigation, and evidence-based management of neonatal seizures to improve outcomes. It also calls for further research into neonatal neurophysiology, the development of safer anticonvulsant therapies, and standardized treatment protocols.